Sign in

You're signed outSign in or to get full access.

William H.C. Chang

Director at Semler Scientific
Board

About William H.C. Chang

William H.C. Chang, age 69, is a Class I director at Semler Scientific and has served on the board since April 2023 (and previously from September 2012 to June 2014) . He holds a bachelor’s degree in economics from Harvard University and is chairman of Westlake Realty Group and Westlake International Group, with more than 40 years of experience; he is also a partner in Digikey Investment Holdings and a principal partner in the San Francisco Giants . He is currently on the board of Ensysce Biosciences, Inc. (since 2008), and has prior board roles with the Asia Foundation and the San Francisco Port and Social Services Commissions; he is a former chairman of the U.S. Rugby Football Union . Chang is nominated for re-election at the September 5, 2025 annual meeting to serve until 2028 .

Past Roles

OrganizationRoleTenureCommittees/Impact
Westlake Realty Group; Westlake International GroupChairman>40 yearsLong-term leadership in real estate and international business
Digikey Investment HoldingsPartnerNot disclosedEarly-stage tech investing focus (clean/green, M2M, mobile, cloud)
San Francisco Giants (MLB)Principal PartnerNot disclosedMajor sports franchise partner
U.S. Rugby Football UnionFormer ChairmanNot disclosedNational sports governance

External Roles

OrganizationRoleTenureNotes
Ensysce Biosciences, Inc.DirectorSince 2008Current public company board
Asia FoundationDirector (prior)Not disclosedPrior non-profit board
SF Port & Social Services CommissionsCommissioner (prior)Not disclosedPrior municipal commissions

Board Governance

Committee2024 Membership2025 Composition/Chair2024 Meetings
AuditChang, Messina, SemlerMessina (Chair), Chang, Brunell 4
CompensationChang, SemlerChang, Brunell 1
Nominating & Corporate GovernanceChang, Messina, SemlerChang, Messina 0
Bitcoin StrategyChang, Semler, Murphy‑ChutorianSemler (Chair), Chang, Murphy‑Chutorian, Brunell 0 (formed May 2024)
  • Independence: The board determined Chang is independent under Nasdaq standards .
  • Attendance: The board met five times in 2024; each director then in office attended at least 75% of board and committee meetings .
  • Annual meeting engagement: Only one director attended the 2024 annual stockholder meeting (no formal policy on director attendance) .
  • Tenure/class: Class I director; up for election September 5, 2025 to serve until 2028 .

Fixed Compensation

ComponentAmount/StructurePeriod/DateNotes
Fees Earned (Cash)$74,250FY2024Board/committee retainers
Board Retainer (policy)$45,000 (non-employee director); $82,500 (non-employee chair)FY2024 policyRetainers paid quarterly
Audit Committee (cash)$11,250 member; $22,500 chairFY2024 policyQuarterly payments
Compensation Committee (cash)$7,500 member; $15,000 chairFY2024 policyQuarterly payments
Nominating Committee (cash)$3,000 member; $7,500 chairFY2024 policyQuarterly payments
2025 Board Cash PolicyCash eliminated; equity-onlyEffective Jan 2025See option structure below

Performance Compensation

Award TypeGrant DateQuantity/TermsValuation/Notes
Stock Awards (Board service)May 20242,182 shares (fully vested on grant)Determined as $50,000 / closing price; granted under 2014 Plan
Stock Awards (Board service)Nov 20241,318 shares (fully vested on grant)$50,000 / closing price; granted under 2024 Plan
Option Award (Bitcoin Strategy Committee)May 23, 202427,000 options; $23.32 exercise; 2-year termGranted under 2014 Plan; service-based committee award

2025 non-employee director equity policy (structure applies to Chang’s roles):

  • Board member options: 5,000 annually (6,000 for chair); vest monthly over 12 months; 10-year term; vested options exercisable for full 10 years post-separation .
  • Audit: 750 member; 1,500 chair; vest monthly over 12 months; 10-year term .
  • Compensation: 500 member; 1,000 chair; vest monthly over 12 months; 10-year term .
  • Nominating: 375 member; 750 chair; vest monthly over 12 months; 10-year term .
  • Bitcoin Strategy: 1,000 member; 150,000 chair; vest monthly over 24 months; expire 24 months after grant .
  • May 2025 additional equity for increased time commitments: Board 2,500 (3,000 chair); Audit 375 (750 chair); Compensation 250 (500 chair); Nominating 185 (375 chair); Bitcoin Strategy 500 member; 75,000 chair; same vesting/term rules .

Other Directorships & Interlocks

Company/OrganizationTypeRolePotential Interlock
Ensysce Biosciences, Inc.Public companyDirector (since 2008)None disclosed with SMLR customers/suppliers
Asia FoundationNon-profitPrior directorNone disclosed
SF Port & Social Services CommissionsMunicipalPrior commissionerNone disclosed
San Francisco GiantsPrivate sports franchisePrincipal partnerNone disclosed

Expertise & Qualifications

  • Early-stage medical and technology company investor/director with focus on clean/green, M2M, mobile, and cloud applications .
  • Harvard University economics degree; decades of leadership in real estate/international business and sports governance .
  • Broad network across private investing and public company board service (Ensysce) .

Equity Ownership

MeasureAmountAs OfNotes
Total Beneficial Ownership910,017 sharesJune 30, 20256.6% of outstanding common shares
Ownership % of Common6.6%June 30, 2025Based on 13,688,405 shares outstanding
Options Exercisable (≤60 days)24,336 sharesJune 30, 2025Included in beneficial ownership
Grantor Retained Annuity Trusts199,596 sharesJune 30, 2025Personal trusts
W&D Chang Family Trust444,577 sharesJune 30, 2025Family trust holdings
Chang 2020 GP LP241,508 sharesJune 30, 2025LP; Chang/spouse manage GP; shared voting/investment control

Policy signals:

  • Insider trading policy prohibits short sales, derivatives, and hedging; addresses pledging risk by highlighting margin/pledge risks; prohibits derivative/hedging transactions by directors .
  • Section 16(a) compliance: Officers and directors complied with filing requirements in 2024 .

Governance Assessment

  • Independence and breadth: Chang is an independent director, serving across Audit, Compensation, Nominating, and Bitcoin Strategy committees—broad coverage that enhances oversight breadth but concentrates influence .
  • Attendance and engagement: Board met five times in 2024 with ≥75% attendance by each director, but only one director attended the 2024 annual meeting—stockholder engagement optics could be improved .
  • Compensation mix evolution: 2024 compensation included cash ($74,250), stock ($100,000), and options ($279,450); 2025 shifts to equity-only with generous option structures and extended post-separation exercisability—alignment via equity, but option-heavy pay and unusual terms warrant scrutiny, especially around Bitcoin Strategy committee awards .
  • Ownership alignment: Significant insider ownership (6.6%) via direct, trust, and partnership structures indicates strong skin-in-the-game; monitor for any future pledging (policy discourages) and potential influence on capital structure/treasury strategy .
  • Related-party/entrenchment risk: 2023 cooperation agreement with fellow >5% holder Eric Semler added both to the board and embedded voting commitments; in 2025 Semler is Executive Chairman and a paid consultant ($30,000/month) to advance the Bitcoin strategy—Chang’s joint roles across committees require continued vigilance for independence and fair process .
  • Capital structure signals: Board proposals to materially increase authorized common stock (to 210,000,000) and authorize 42,000,000 “blank-check” preferred stock have stated strategic rationale tied to Bitcoin accumulation and flexibility but include explicit anti-takeover effects—investors should assess dilution risk and governance safeguards .

RED FLAGS

  • Cooperation agreement with >5% holders influencing board composition and voting commitments; potential entrenchment dynamics .
  • Elimination of cash director pay and reliance on large, flexible option grants (including special Bitcoin committee grants and extended exercisability) that may weaken pay discipline and introduce misalignment if performance hurdles are absent .
  • Capital authorization proposals with acknowledged anti-takeover effects; substantial dilution capacity relative to current shares outstanding .

Positive Signals

  • Independent status affirmed; multi-committee participation enhances oversight coverage .
  • Strong personal ownership (6.6%) and compliance with insider reporting; robust insider trading/hedging prohibitions .
  • Audit committee chaired by an audit committee financial expert (Messina), with Chang as member—supports financial reporting oversight .